跳转至内容
Merck
CN
  • The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2014-03-13)
Terence W Friedlander, Lawrence Fong